June 2020 ZOHU Call
- Overview of the Meat and Poultry Processing Interim Guidance from the Centers for Disease Control and Prevention and the Occupational Safety and Health Administration
- Assessing the Risks of Reverse Zoonotic Transmission of SARS-CoV-2 from Humans to North American Wildlife
- Development of Rabies Post-Exposure Prophylaxis Quality Improvement Program at a Multi-Hospital Health System
Date: Wednesday, June 3, 2020
Presentations:
One Health News from CDC
Casey Barton Behravesh, MS, DVM, DrPH, DACVPM
Captain, U.S. Public Health Service
Director, One Health Office
Centers for Disease Control and Prevention
dlx9@cdc.gov
Overview of the Meat and Poultry Processing Interim Guidance from the Centers for Disease Control and Prevention and the Occupational Safety and Health Administration
Suzanne Tomasi, DVM, MPH, DACVPM
Epidemiologist
Field Studies Branch
Respiratory Health Division
National Institute for Occupational Safety and Health
Centers for Disease Control and Prevention
yxc4@cdc.gov
Assessing the Risks of Reverse Zoonotic Transmission of SARS-CoV-2 from Humans to North American Wildlife
Jonathan Sleeman, MA, VetMB, Dipl. ACZM, MRCVS
Center Director
National Wildlife Health Center
United States Geologic Survey
jsleeman@usgs.gov
Development of Rabies Post-Exposure Prophylaxis Quality Improvement Program at a Multi-Hospital Health System
Joshua T. Swan, PharmD, MPH, FCCM, BCPS
Associate Professor of Pharmacy in Surgery and Outcomes Research
Houston Methodist Hospital
JTSwan@houstonmethodist.org
Resources
Overview of the Meat and Poultry Processing Interim Guidance from the Centers for Disease Control and Prevention and the Occupational Safety and Health Administration
- Meat and Poultry Processing Workers and Employers: Interim Guidance from CDC and the Occupational Safety and Health Administration (OSHA)
- Implementing Safety Practices for Critical Infrastructure Workers Who May Have Had Exposure to a Person with Suspected or Confirmed COVID-19
Assessing the Risks of Reverse Zoonotic Transmission of SARS-CoV-2 from Humans to North American Wildlife
Development of Rabies Post-Exposure Prophylaxis Quality Improvement Program at a Multi-Hospital Health System
Overall series objectives:
- Describe 2 key points from the presentation.
- Describe how a multisectoral One Health approach can be applied to the presentation topic.
- Identify an implication for animal and human health.
- Identify a One Health approach strategy for prevention, detection, or response to public health threats.
- Identify 2 new resources from CDC partners.
Disclosures:
In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Dr. Joshua T. Swan and he wishes to disclose that an advisor board stipend was paid to his employer by Kedrion Biopharmacueticals, and investigator-initiated research funding was paid to his employer by Grifols (both are manufacturers of rabies immune globulin).
The planning committee reviewed content to ensure there is no bias.
The presentations will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this activity.
